Neoglycoproteins

US6723831B2 · kind B2 · utility

Assignee

• Novartis AG · CH

Inventors

• Rudolf Duthaler · Bettingen, CH
• Andreas Katopodis · Oberwil, CH
• Willy Kinzy · Lörrach, DE
• Reinhold Öhrlein · Rheinfelden (Baden), DE
• Gebhard Thoma · Lörrach, DE

Key dates

• Filing date: Apr 16, 2002
• Grant date: Apr 20, 2004
• Expiry date: Apr 16, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Polyamide conjugates comprising either (a) a xenoantigenic group; or (b) a biologically active group and a macromolecular, macro- or microscopic entity; bound to a polyamide backbone, processes for their preparation and the use of these conjugates in therapeutic compositions.